Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: The role of RELB [Oncotarget., 9, (2018), (7631-7643)] DOI: 10.18632/oncotarget.24146

Po Hao Feng, Chih Teng Yu, Kuan Yuan Chen, Ching Shan Luo, Shen Ming Wu, Chien Ying Liu, Lu Wei Kuo, Yao Fei Chan, Tzu Tao Chen, Chih Cheng Chang, Chun Nin Lee, Hsiao Chi Chuang, Chiou Feng Lin, Chia Li Han, Wei Hwa Lee, Kang Yun Lee

Research output: Contribution to journalComment/debate

Abstract

This study was supported by National Science Council (NSC 102-2314-B-038-048) to PHF, Ministry of Science and Technology (MOST 103-2314-B-038 -056 and 104-2314-B-038-070) to PHF, and Taipei Medical University (TMU103- AE1-B31, TMU103-AE2-I01-3, 103TMU-SHH-01-2, 105TMU-SHH-02-2) to PHF.

Original languageEnglish
Pages (from-to)31559
Number of pages1
JournalOncotarget
Volume9
Issue number59
DOIs
StatePublished - 31 07 2018
Externally publishedYes

Bibliographical note

Publisher Copyright:
© Feng et al.

Fingerprint

Dive into the research topics of 'Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: The role of RELB [Oncotarget., 9, (2018), (7631-7643)] DOI: 10.18632/oncotarget.24146'. Together they form a unique fingerprint.

Cite this